Show simple item record

dc.contributor.authorBarriuso, Jorge
dc.contributor.authorBenavent, M
dc.contributor.authorLamarca, Angela
dc.contributor.authorBernal, E
dc.contributor.authorGuerra-Pastrian, L
dc.contributor.authorHeredia, V
dc.contributor.authorMiguel, V
dc.contributor.authorGarcia-Calderon, C
dc.contributor.authorAlvarez-Escola, C
dc.contributor.authorCastell, J
dc.contributor.authorCustodio, A
dc.contributor.authorBurgos, E
dc.contributor.authorFeliu, J
dc.contributor.authorCarbonero, G
dc.contributor.authorMendiola, M
dc.date.accessioned2017-01-06T10:17:56Z
dc.date.available2017-01-06T10:17:56Z
dc.date.issued2016
dc.identifier.citationValidation of lysyl oxidase-like 2 (LOXL2) as prognostic marker for gastro-entero-pancreatic neuroendocrine tumours (GEP-NET) Using an independent cohort. 2016, 103:44-44 Neuroendocrinologyen
dc.identifier.urihttp://hdl.handle.net/10541/620064
dc.language.isoenen
dc.titleValidation of lysyl oxidase-like 2 (LOXL2) as prognostic marker for gastro-entero-pancreatic neuroendocrine tumours (GEP-NET) Using an independent cohorten
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Manchester, Manchester, UKen
dc.identifier.journalNeuroendocrinologyen


This item appears in the following Collection(s)

Show simple item record